Volume 91 Issue 32 | p. 17 | Concentrates
Issue Date: August 12, 2013

Roche Grants License For Eye Disease Drug

Department: Business
Keywords: HIV, world health, patents, pharmaceuticals

Roche and the Medicines Patent Pool have inked a supply agreement for Valcyte, an oral treatment for cytomegalovirus, a viral infection that can cause blindness and affects roughly one in 10 people living with HIV in low- and middle-income countries. Medicines Patent Pool is a United Nations-backed mechanism that lowers HIV drug prices by making patent licenses available to generic drug firms. Under the pact, Valcyte will be available . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society